US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VictoryShares US EQ Income Enhanced Volatility Wtd ETF

62.51

+0.63001.02%

Post-market: 62.660.1500+0.24%16:05 EDT

Volume:18.75K

Turnover:1.17M

Market Cap:731.37M

PE:- -

High:62.67

Open:62.46

Low:62.13

Close:61.88

Loading ...

Overview Company News Filings

Latham Teams With Olympic Gold Medalist and World Champion Skier Bode Miller to Promote Pool Safety Reminders for Water Safety Month

BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma

GE2025: Eight parties deliver campaign messages in final political broadcast

MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

Cruise Ship Norovirus Outbreaks Rise in 2025 as New Strain Emerges, CDC Says

GE2025: Opposition never mentions having alternative voices in parliament is 'guaranteed', says Indranee

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation

GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater

GE2025: SDP leaders urge voters to 'send a message' to PM Wong about GST hikes, cost of living pressures

FairPrice marks May Day with 50-cent coffee or tea, 50% off essentials for members

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey

GE2025: SPP launches manifesto, proposes distributing government surpluses as CDC vouchers

Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention

Simply Wall St.

Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

GSK Says CDC Panel Recommends Penmenvy for Adolescent Meningococcal Vaccination

AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDC\",,,,,undefined,":{"symbol":"CDC","market":"US","secType":"STK","nameCN":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","latestPrice":62.51,"timestamp":1746216000000,"preClose":61.88,"halted":0,"volume":18746,"hourTrading":{"tag":"盘后","latestPrice":62.66,"preClose":62.51,"latestTime":"16:05 EDT","volume":4,"amount":250.64,"timestamp":1746216312733},"delay":0,"floatShares":11700000,"shares":11700000,"eps":0,"marketStatus":"Post-Mkt","change":0.63,"latestTime":"05-02 16:06:45 EDT","open":62.46,"high":62.6726,"low":62.13,"amount":1170907.534342,"amplitude":0.008769,"askPrice":71.39,"askSize":100,"bidPrice":54.23,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746230400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.88,"sharesOutstanding":11700000,"nav":62.294372,"aum":728844480,"bidAskSpread":0.000963,"postHourTrading":{"tag":"盘后","latestPrice":62.66,"preClose":62.51,"latestTime":"16:05 EDT","volume":4,"amount":250.64,"timestamp":1746216312733},"volumeRatio":0.74535,"impliedVol":0.0768,"impliedVolPercentile":0.66},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDC\",,,,,undefined,":{"symbol":"CDC","floatShares":11700000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.74535,"shares":11700000,"dividePrice":2.06991,"high":62.6726,"amplitude":0.008769,"preClose":61.88,"low":62.13,"week52Low":57.37,"pbRate":"--","week52High":67.7599,"institutionHeld":0,"latestPrice":62.51,"eps":0,"divideRate":0.033113,"volume":18746,"delay":0,"ttmEps":0,"open":62.46,"prevYearClose":62.58,"prevWeekClose":61.745,"prevMonthClose":62.35,"prevQuarterClose":65.72,"fiveDayClose":61.745,"twentyDayClose":63.6681,"sixtyDayClose":64.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532262848","title":"Latham Teams With Olympic Gold Medalist and World Champion Skier Bode Miller to Promote Pool Safety Reminders for Water Safety Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2532262848","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532262848?lang=en_us&edition=fundamental","pubTime":"2025-05-02 23:17","pubTimestamp":1746199020,"startTime":"0","endTime":"0","summary":"LATHAM, N.Y., May 02, 2025  -- With summer just around the corner, Latham, The Pool Company [NASDAQ:SWIM], is reminding families to prioritize safety as we head into peak swimming season. During National Water Safety Month this May, the leading manufacturer of in-ground residential swimming pools is teaming up with Olympic and World Championship gold medalist and two-time Overall World Cup Champion Bode Miller to share essential pool safety tips with the goal of helping to prevent accidents and ensuring that homeowners can enjoy their pools with confidence.“Drowning prevention is a cause that’s deeply personal to me, which is why I’ve partnered with Latham and Coverstar to help raise awareness about the importance of pool safety,” said Bode Miller, whose 19-month-old daughter accidentally drowned in a neighbor’s pool back in 2018. “Simple steps like swim lessons and installing an autocover can make all the difference in keeping kids safe around the water.”Following are five essential w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/latham-teams-olympic-gold-medalist-151700743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["POOL","BK4567","SWIM","BK4588","BK4535","CDC","MLR","BK4539","BK4159","BK4149","BK4559","BK4585","BK4190","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2532810675","title":"BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2532810675","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532810675?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:00","pubTimestamp":1746183600,"startTime":"0","endTime":"0","summary":"KALOS and LOGOS were replicate, randomized, double-blind trials designed to investigate BREZTRI as a potential treatment for asthma.1,2 The trials evaluated the efficacy and safety of BREZTRI versus maintenance treatment with ICS/LABA in adults and adolescents with uncontrolled asthma.1,2. Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca, said: \"We are excited by the positive results from the KALOS and LOGOS trials, which demonstrate that BREZTRI could help improve the lives of the millions of patients living with asthma. These asthma data build on the well-established profile of BREZTRI in COPD, and we look forward to sharing with regulatory authorities to bring this important medicine to a wider group of patients.\". There were no new safety or tolerability signals identified for BREZTRI in KALOS or LOGOS.Full results from the two Phase III trials will be shared with regulatory authorities and presented at an upcoming medical meeting.BREZTRI is an inhaled tri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/breztri-met-primary-endpoints-kalos-110000396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU2456880835.USD","BK4134","BK4568","LU2417539215.USD","LU0320765992.SGD","LU2462157665.USD","BK4585","CDC","LU0109394709.USD","LU1829250122.USD","LU2236285917.USD","AZN","III","BK4588","LU0889565916.HKD"],"gpt_icon":0},{"id":"2532832494","title":"GE2025: Eight parties deliver campaign messages in final political broadcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2532832494","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532832494?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:12","pubTimestamp":1746105120,"startTime":"0","endTime":"0","summary":"In the second and last political broadcast for the 2025 General Election, candidates from eight parties delivered their final pitches to voters. ","market":"us","thumbnail":"https://dam.mediacorp.sg/image/upload/s--cfNBGuX0--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/30/PPB%202.png?itok=9HYuLhFF","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--cfNBGuX0--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/30/PPB%202.png?itok=9HYuLhFF"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/ge2025-political-party-broadcast-may-1-pap-wp-rdu-psp-par-sdp-ppp-nsp-5099566","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["BK4157","CPF","PAR","BK4211","CDC"],"gpt_icon":0},{"id":"2532514008","title":"MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races","url":"https://stock-news.laohu8.com/highlight/detail?id=2532514008","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532514008?lang=en_us&edition=fundamental","pubTime":"2025-05-01 21:00","pubTimestamp":1746104400,"startTime":"0","endTime":"0","summary":"The test, run on Abbott's portable i-STAT Alinity hand-held instrument, uses whole blood to help evaluate patients 18 years of age and older with a suspected mild traumatic brain injury, or concussion, producing lab-quality results in 15 minutes. The test will be used by healthcare professionals in the medical facilities at all MotoAmerica races in 2025. ABBOTT PARK, Ill., and IRVINE, Calif., May 1, 2025 /PRNewswire/ -- Abbott , the global healthcare company, and MotoAmerica, the premier motorcycle road racing series in North America, announced today that MotoAmerica is the first professional sports organization worldwide to use Abbott's groundbreaking blood test to help assess suspected concussions for riders in the on-site medical facilities at all races.\"The standard of competition and performance in MotoAmerica continues t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/motoamerica-becomes-first-sports-organization-130000553.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/motoamerica-becomes-first-sports-organization-130000553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1914381329.SGD","LU2237957811.SGD","IE00B4R5TH58.HKD","BK4581","IE00BJT1NW94.SGD","BK4592","IE00B2B36J28.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999002232.USD","LU1023059063.AUD","LU2089984988.USD","BK4568","SGXZ23171101.USD","BK4082","IE0002141913.USD","LU2237957902.USD","LU0266013472.USD","LU0122379950.USD","ABT","LU1057294990.SGD","LU0868494617.USD","SG9999004303.SGD","LU2112291526.USD","BK4566","CDC","BK4585","IE0009355771.USD","LU0234572021.USD","BK4533","LU1691799644.USD","LU1721429402.USD","LU1989763427.SGD","LU2133065610.SGD","BK4504","LU1721429741.USD","BK4588","LU1061106388.HKD","LU0170899867.USD","LU1989763690.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2531816437","title":"Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2531816437","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531816437?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:45","pubTimestamp":1745923500,"startTime":"0","endTime":"0","summary":"Delivers Robust Earnings Performance, Successfully Navigating a Dynamic Environment. NEW YORK, April 29, 2025----Pfizer Inc.  reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance.\"Our overall solid first-quarter performance demonstrates our continued focus on commercial execution amid U.S. Medicare Part D headwinds. Our focus on operational efficiency and financial discipline is driving strong results to our bottom line. We are currently trending towards the upper end of our 2025 Adjusted diluted EPS guidance range.\". First-Quarter 2025 Revenues of $13.7 Billion, Reported Diluted EPS of $0.52, and Adjusted Diluted EPS of $0.92. On Track to Deliver Operating Margin Expansion from Ongoing Cost Realignment Program with Approximately $4.5 Billion of Net Cost Savings by End of 2025, and Announces Additional Productivity Gains Expected Through 2027 Leveraging Digital Enablement and Process Simplification. First Phase of Manufacturing Optimizatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-reports-solid-first-quarter-104500122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","SG9999013999.USD","SG9999002224.SGD","LU0321505439.SGD","BNTX","BK4022","PFS","BK4599","BK4213","LU1066051498.USD","LU1066053197.SGD","PFE","ITT","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","SG9999002232.USD","LU0868494617.USD","LU0170899867.USD","LU0225284248.USD","LU0234572021.USD","IE0002270589.USD","BK4195","LU0054578231.USD","LU0053671581.USD","BK4135","BK4533","BK4535","LU1894683348.USD","BCG","LU0122379950.USD","BK4230","BK4548","EC","LU0058720904.USD","OS","LU1894683264.USD","CAR","LU1057294990.SGD","SOC","IE000M9KFDE8.USD","BK4550","LU0289739699.SGD","BK4581","LU0321505868.SGD","BK4585","SGXZ57979304.SGD","CDC","LU0225771236.USD"],"gpt_icon":1},{"id":"2531266569","title":"Cruise Ship Norovirus Outbreaks Rise in 2025 as New Strain Emerges, CDC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266569","media":"GuruFocus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531266569?lang=en_us&edition=fundamental","pubTime":"2025-04-29 02:41","pubTimestamp":1745865685,"startTime":"0","endTime":"0","summary":"Cruise ships are seeing a rise in norovirus outbreaks this year, with 13 reported so far, according to the Centers for Disease Control and Prevention. Ten of the outbreaks have been linked to noroviru","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2808686/cruise-ship-norovirus-outbreaks-rise-in-2025-as-new-strain-emerges-cdc-says","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2530441240","title":"GE2025: Opposition never mentions having alternative voices in parliament is 'guaranteed', says Indranee","url":"https://stock-news.laohu8.com/highlight/detail?id=2530441240","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530441240?lang=en_us&edition=fundamental","pubTime":"2025-04-28 14:42","pubTimestamp":1745822520,"startTime":"0","endTime":"0","summary":"The opposition has also been trying to sell Singaporeans a \"myth\" that it is okay to vote for more of them and still get the same result, said Minister in the Prime Minister's Office Indranee Rajah.","market":"sg","thumbnail":"https://dam.mediacorp.sg/image/upload/s--kOAxD-ZE--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/28/_wal1215.jpg?itok=bbwLk3dr","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--kOAxD-ZE--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/28/_wal1215.jpg?itok=bbwLk3dr"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/ge2025-pap-ncmp-opposition-guaranteed-indranee-5094046","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["GST","CDC"],"gpt_icon":0},{"id":"2530115238","title":"Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530115238","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530115238?lang=en_us&edition=fundamental","pubTime":"2025-04-25 23:27","pubTimestamp":1745594820,"startTime":"0","endTime":"0","summary":"DUBLIN, April 25, 2025 /PRNewswire/ --Jazz Pharmaceuticals plc  today announced that the Committee for Medicinal Products for Human Use  of the European Medicines Agency  has adopted a positive opinion recommending the conditional marketing authorization of zanidatamab, an investigational dual human epidermal growth factor receptor 2 -targeted bispecific antibody, as monotherapy for the treatment of adults with unresectable locally advanced or metastatic HER2-positive  biliary tract cancer  previously treated with at least one prior line of systemic therapy.1. \"This positive CHMP opinion is a welcome step for physicians and patients in Europe who face a critical unmet need in HER2-positive biliary tract cancers, a rare and aggressive group of cancers with poor prognosis and limited treatment options,\" said Robert Iannone, MD., M.S.C.E., executive vice president, global head of research and development, and chief medical officer of Jazz Pharmaceuticals. \"If approved, zanidatamab would b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-receives-chmp-positive-152700121.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-receives-chmp-positive-152700121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BN0W2V16.EUR","CHMP","LU0823416689.USD","BK4007","LU0320765992.SGD","LU0889565916.HKD","BK4087","IE00B7SZL793.SGD","JAZZ","BK4533","BK4156","HCC","BK4006","IE00B19Z4B17.USD","BTC","BK4532","AEIS","IE00B66KJ199.SGD","IE00BN0W2W23.USD","BK4157","IE0031619046.USD","LU0109394709.USD","CCA","CDC","IE00BN0W2T93.GBP"],"gpt_icon":0},{"id":"2530136602","title":"Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation","url":"https://stock-news.laohu8.com/highlight/detail?id=2530136602","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530136602?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:10","pubTimestamp":1745586600,"startTime":"0","endTime":"0","summary":"BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd  , a one-stop AI video solution provider, announced a Letter to Investors, in which Baijiayun CEO Mr. Yi Ma stated that following its partnership with Xinlantian, the company plans to invest tens of millions of dollars over the next five years to establish new ecosystem for autism rehabilitation.According to data from the 2023 China Disability Census Report, the number of autistic patients in China has exceeded 13 million, making it the leading cause of mental disabilities among Chinese children. Currently, there are approximately 2 million children with autism aged 0-14 nationwide, with an annual increase of about 160,000. The latest report released by the US Centers for Disease Control and Prevention  in April this year also shows that about 1 in 31 US children is affected, indicating that the significant increase in the incidence of autism has become a global issue.According to data from the 2023 China Disability Census Rep","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/baijiayun-announces-plan-invest-tens-131000389.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/baijiayun-announces-plan-invest-tens-131000389.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BGSX","CAGR","BK4090","RTC","CDC","BK4023","BK4159"],"gpt_icon":0},{"id":"2530094999","title":"GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater","url":"https://stock-news.laohu8.com/highlight/detail?id=2530094999","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530094999?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:02","pubTimestamp":1745524973,"startTime":"0","endTime":"0","summary":"GEO-MVA Advancing as the Leading U.S.-Developed Mpox Vaccine Candidate. ATLANTA, GA - April 24, 2025  - GeoVax Labs, Inc. , a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today responded to the recent detection of Clade I Mpox viral particles in wastewater samples in Greenville, North Carolina - the first such identification in the state. This finding, disclosed by the North Carolina Department of Health and Human Services , underscores the increasing threat posed by Clade I Mpox and the urgent need for expanded preparedness and Mpox vaccine availability.This development aligns with concerns raised by the Centers for Disease Control and Prevention , which continues to monitor Clade I Mpox - a more virulent strain associated with higher transmissibility and a greater case fatality rate than Clade II. Four confirmed Clade I Mpox cases have been reported in the U.S. to date - in California, Georgia, New Hampshire, and New","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geovax-responds-detection-clade-mpox-200253222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4022","CARO","GOVX","BK4232","CDC","R","GOVXW"],"gpt_icon":0},{"id":"2530968872","title":"GE2025: SDP leaders urge voters to 'send a message' to PM Wong about GST hikes, cost of living pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2530968872","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530968872?lang=en_us&edition=fundamental","pubTime":"2025-04-25 00:33","pubTimestamp":1745512380,"startTime":"0","endTime":"0","summary":"\"We will spell out for you an alternative vision for our nation,\" says Singapore Democratic Party chief Chee Soon Juan. ","market":"sg","thumbnail":"https://dam.mediacorp.sg/image/upload/s--vpqNT7gn--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/24/5787175725500057298_mod.jpg?itok=P0f43sgX","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--vpqNT7gn--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/24/5787175725500057298_mod.jpg?itok=P0f43sgX"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/ge2025-sdp-rally-singapore-democratic-party-chee-soon-juan-paul-tambyah-5086031","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["BK4211","GRC","BK4161","CDC","5GC.SI","GST","SDP","CPF"],"gpt_icon":0},{"id":"2529939621","title":"FairPrice marks May Day with 50-cent coffee or tea, 50% off essentials for members","url":"https://stock-news.laohu8.com/highlight/detail?id=2529939621","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529939621?lang=en_us&edition=fundamental","pubTime":"2025-04-24 12:59","pubTimestamp":1745470740,"startTime":"0","endTime":"0","summary":"SINGAPORE: NTUC Union and Link members will once again be able to enjoy 50-cent hot coffee or tea at 70 Kopitiam outlets islandwide from May 1 to May 31, FairPrice Group announced in a statement on Thursday .The promotion, in partnership with Kopitiam, is being offered as part of the group's May Day and SG60 celebration this year.To buy the 50-cent beverages, members will have to present their physical silver NTUC Union card or use an e-voucher and make payment via the FairPrice app at checkout.From Thursday, members can also get 50 per cent off a new essential item every Thursday forfour weeks, both in-store and online. However, a member may only buy two units per item on each day.FairPrice Group said it has pledged over S$5 million  worth of savings this year – the largest amount it has committed for its annual May Day campaign.FairPrice Group added that it has launched several SG60 initiatives this year, including discounts on its house brand products and return vouchers to suppleme","market":"nz","thumbnail":"https://dam.mediacorp.sg/image/upload/s--EhCs98kB--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/24/IMG_9223.jpeg?itok=NRQBp4VB","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--EhCs98kB--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/04/24/IMG_9223.jpeg?itok=NRQBp4VB"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/ntuc-fairprice-coffee-kopitiam-sg60-may-day-5085551","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2529668143","title":"Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2529668143","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529668143?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:15","pubTimestamp":1745439300,"startTime":"0","endTime":"0","summary":"Statistically significant and clinically meaningful progression-free survival  and overall survival  data for Zepzelca  and atezolizumab  combination underscore potential of first-line maintenance therapy for extensive-stage small cell lung cancer, a much-needed advancement for patients. Long-term outcomes and survival data for Ziiherahighlight its potential to reshape the treatment paradigm for newly diagnosed HER2+ gastroesophageal cancer patients. Efficacy and safety of dordaviprone  in prospective clinical trials of adult and pediatric recurrent H3 K27M-mutant diffuse glioma patients. Jazz to host investor webcast on Tuesday, June 10 to review Zepzelca data. An oral abstract of the Phase 3 IMforte trial, which showed statistically significant and clinically meaningful survival benefit (progression-free survival (PFS) and overall survival (OS) for the combination of Zepzelca and atezolizumab (Tecentriq) for extensive-stage small cell lung cancer (ES-SCLC) patients receiving treatmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-showcases-transformative-data-201500637.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-showcases-transformative-data-201500637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","IE00BN0W2W23.USD","BK4007","IHC","IE00BN0W2T93.GBP","BK4211","LU0320765992.SGD","LU0823416689.USD","BK4097","IE00BN0W2V16.EUR","LU0109394709.USD","BTC","OS","PFS","BK4197","JAZZ","CPK","BK4162","BK4195","BK4533","ORR","CDC","LU0889565916.HKD"],"gpt_icon":0},{"id":"2529307763","title":"Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307763?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:44","pubTimestamp":1745325840,"startTime":"0","endTime":"0","summary":"In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people in that category.At the time they replied to the survey, 3.7 percent of respondents – equivalent to about 9.9 million people – reported they had been experiencing fatigue, a common symptom of babesiosis, for six months or longer.The online quantitative survey was conducted among a general adult population sample of 6,000 adults, with demographic variables  matched to U.S. census data for optimal representation of the U.S. population. Babesiosis was reported as a diagnosed medical condition experienced by 1.26 percent of respondents, implying that 3 million Americans may have experienced babesiosis . Moreover, approximately 17 percent of babesiosis patien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/babesiosis-disease-burden-united-states-124400994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTP","BK4211","UBCP","CDC","BK4007","SXTPW"],"gpt_icon":0},{"id":"2528023465","title":"GE2025: SPP launches manifesto, proposes distributing government surpluses as CDC vouchers","url":"https://stock-news.laohu8.com/highlight/detail?id=2528023465","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528023465?lang=en_us&edition=fundamental","pubTime":"2025-04-19 01:55","pubTimestamp":1744998957,"startTime":"0","endTime":"0","summary":"[SINGAPORE] The Singapore People’s Party (SPP) has launched its manifesto ahead of the 2025 General Election on May 3.  ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/singapore/ge2025-spp-launches-manifesto-proposes-distributing-government-surpluses-cdc-vouchers","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/singapore/ge2025-spp-launches-manifesto-proposes-distributing-government-surpluses-cdc-vouchers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2528722823","title":"Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2528722823","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528722823?lang=en_us&edition=fundamental","pubTime":"2025-04-18 01:25","pubTimestamp":1744910734,"startTime":"0","endTime":"0","summary":"Pfizer recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at increased risk. Despite this positive development, Pfizer's shares saw a 2% decline over the past week. This move is in line with broader market trends, as the market dropped by 3% during the same period. The company's decision to halt development of Danuglipron, an oral weight loss drug, due to safety concerns, may have also added weight to the downward pressure on its shares, amid wider concerns impacting the healthcare sector and investor sentiment surrounding safety in drug development.Pfizer has 3 possible red flags  we think you should know about.The recent CDC recommendation for Pfizer's RSV vaccine, ABRYSVO, is a promising development that could positively impact the company's revenue and earnings forecasts; however, the decision to halt development of the Danuglipron weight loss drug amplifies concerns over safety in drug development. This mix of news, coupled with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-nyse-pfe-gets-cdc-172534992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","CDC","BK4533","SG9999003800.SGD","NYSE","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2528723115","title":"Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars","url":"https://stock-news.laohu8.com/highlight/detail?id=2528723115","media":"Quartz","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528723115?lang=en_us&edition=fundamental","pubTime":"2025-04-17 23:20","pubTimestamp":1744903245,"startTime":"0","endTime":"0","summary":"The first GLP-1 pill could be in medicine cabinets sooner than expected.Eli Lilly  announced Thursday that its daily obesity pill, orforglipron, met company goals in the first of several late-stage trials — helping patients with Type 2 diabetes lower their blood sugar while causing weight loss. The results were comparable with other GLP-1 injections on the market, such as Ozempic and Mounjaro.Orforglipron could give Lilly a key advantage over other pharmaceutical giants in the GLP-1 realm. Lilly’s stock was up 11% in premarket trading. Novo Nordisk , which makes Ozempic, was down 6%.The results are pivotal: While the GLP-1 class of medication has become a blockbuster on the market , they’re expensive, must be injected, and need to be kept refrigerated. A pill version would be a more convenient option that could be much more widely used.The study measured weight loss as a secondary goal. Patients who received orforglipron also reported weight loss — up to 16 pounds without","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lillys-weight-loss-pill-152045475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0106261372.USD","LU1366192091.USD","LU1720051017.SGD","LU0114720955.EUR","LU0203201768.USD","LU2357305700.SGD","LU1917777945.USD","LU0289739699.SGD","LU2750360997.AUD","LU1551013342.USD","LLY","LU0823416689.USD","LU2750360641.GBP","LU0109391861.USD","LU1280957306.USD","RHHBY","LU0820561909.HKD","LU0006306889.USD","LU2237438978.USD","BK4588","LU2602419157.SGD","LU2361044865.SGD","03165","LU2361045086.USD","SG9999014906.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0882574139.USD","LU1868836914.USD","SG9999017495.SGD","SG9999015952.SGD","SGXZ81514606.USD","LU0256863902.USD","LU0456855351.SGD","LU0354030438.USD","LU0466842654.USD","SG9999018857.SGD","LU2237443549.SGD","LU0320765059.SGD","LU1267930730.SGD","IE00BKVL7J92.USD","IE00B2B36J28.USD","CDC","LU1127390331.HKD","IE0004445239.USD","NVO","LU1868837300.USD","GB00BDT5M118.USD","LU1548497426.USD","LU0471298694.HKD"],"gpt_icon":1},{"id":"2528474479","title":"Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2528474479","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528474479?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:15","pubTimestamp":1744895700,"startTime":"0","endTime":"0","summary":"J&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its danuglipron weight loss pill program. The European Commission granted marketing authorization for the expanded use of Roche’s RHHBY cancer drug, Columvi. Sanofi SNY provided an update on its respiratory pipeline.Here's a recap of the week’s most important stories.J&J beat first-quarter estimates for both earnings and sales. Adjusted earnings of $2.77 per share rose 2.2% from the year-ago period. Sales of $21.89 billion rose 2.4% from the year-ago quarter. Innovative Medicines segment sales rose 2.3% year over year to $13.87 billion. MedTech segment sales came in at $8.02 billion, up 2.5% from the year-ago period.The U.S. Centers for Disease Control and Prevention’s  Advisory Committee on Immunization Practices recommended the expanded use of Pfizer and GSK’s respiratory syncytial virus  vaccines, Abrysvo and Arexvy, respectively, in adults aged 50 to 59 at increa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-j-js-131500764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0985320562.USD","IE00BBT3K403.USD","LU1032466523.USD","LU2347655156.SGD","BK4550","LU2129689605.HKD","LU2430703095.HKD","SG9999001176.USD","RHHBY","IE00BVYPNV92.GBP","BK4568","03165","SG9999013999.USD","SNY","LU0170899867.USD","LU1066051225.USD","LU0122379950.USD","LU1162221912.USD","LU1244550494.USD","PFE","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0058720904.USD","LU0795875169.SGD","LU1244550221.USD","LU1778281490.HKD","IE00BFXG1179.USD","IE00B19Z3581.USD","JNJ","LU1066051811.HKD","LU2430703178.SGD","LU2505996509.AUD","SG9999003800.SGD","IE00BGHQF631.EUR","LU2430703251.USD","LU0792757196.USD","IE00BSNM7G36.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0345769128.USD","LU1585245621.USD","SGXZ57979304.SGD","IE00BN8TJ469.HKD","IE0002141913.USD","LU0203345920.USD","LU0098860793.USD","LU1718418525.SGD","CDC","IE00BDGV0183.EUR","BK4581"],"gpt_icon":1},{"id":"2528209335","title":"GSK Says CDC Panel Recommends Penmenvy for Adolescent Meningococcal Vaccination","url":"https://stock-news.laohu8.com/highlight/detail?id=2528209335","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528209335?lang=en_us&edition=fundamental","pubTime":"2025-04-17 05:41","pubTimestamp":1744839660,"startTime":"0","endTime":"0","summary":"GSK said a Centers for Disease Control and Prevention advisory board called for its drug Penmenvy to be part of the adolescent meningococcal vaccination schedule.Penmenvy was recommended to help protect people who are more than 10 years old against disease-causing serogroups of Neisseria meningitidis, as an alternative to the administration of several separate vaccinations, GSK said Wednesday. The recommendation will be reviewed and if adopted would allow for vaccination in fewer doses, which may simplify delivery and improve immunization rates, GSK added.In February, the Food and Drug Administration approved the company's MenABCWY vaccine for use in individuals aged 10 through 25 years.Vaccine doses will be ready for use in the U.S. in summer, GSK said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GSK.UK","CDC","BK4532","LU1829250122.USD","BK4588","GSK","BK4007"],"gpt_icon":0},{"id":"2528357209","title":"AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices","url":"https://stock-news.laohu8.com/highlight/detail?id=2528357209","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528357209?lang=en_us&edition=fundamental","pubTime":"2025-04-17 05:36","pubTimestamp":1744839360,"startTime":"0","endTime":"0","summary":"Over 13 million adults aged 50-59 at increased risk in the US can potentially benefit from RSV immunization1. RSV causes an estimated 42,000 hospitalizations* each year in adults aged 50-64 years old in the US2. PHILADELPHIA, April 16, 2025----GSK plc  is pleased that the Advisory Committee on Immunization Practices  voted in favor of recommending the use of RSV vaccines including GSK’s AREXVY  in adults aged 50-59 who are at increased risk for severe RSV disease. This includes people with conditions like COPD, asthma, diabetes, heart disease and those in residential care3. This expands on ACIP’s previous vote in June 2024 to recommend RSV vaccines for adults aged 60-74 who are at increased risk and all adults aged 75 and older. AREXVY is indicated for the prevention of lower respiratory tract disease  caused by RSV in individuals 60 years of age and older, as well as individuals 50 through 59 years of age who are at increased risk for LRTD caused by RSV.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arexvy-recommended-adults-aged-50-213600054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","BK4585","LU1829250122.USD","CDC","BK4007","GSK","GSK.UK","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":189,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDC\",params:#limit:5,,,undefined,":[{"date":"2025-04-10","symbol":"CDC","amount":0.22096,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-10","defaultRemindTime":1744291800000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-11","payableDate":"2025-04-10","currency":"USD","dateTimestamp":1744257600000,"payDate":"2025-04-11"},{"date":"2025-03-10","symbol":"CDC","amount":0.20589,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-10","defaultRemindTime":1741613400000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-11","payableDate":"2025-03-10","currency":"USD","dateTimestamp":1741579200000,"payDate":"2025-03-11"},{"date":"2025-02-07","symbol":"CDC","amount":0.133071,"announcedDate":"2025-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-07","defaultRemindTime":1738938600000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-10","payableDate":"2025-02-07","currency":"USD","dateTimestamp":1738904400000,"payDate":"2025-02-10"},{"date":"2025-01-08","symbol":"CDC","amount":0.007166,"announcedDate":"2025-01-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-08","defaultRemindTime":1736346600000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-09","payableDate":"2025-01-08","currency":"USD","dateTimestamp":1736312400000,"payDate":"2025-01-09"},{"date":"2024-12-12","symbol":"CDC","amount":0.414202,"announcedDate":"2024-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-12","defaultRemindTime":1734013800000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-13","payableDate":"2024-12-12","currency":"USD","dateTimestamp":1733979600000,"payDate":"2024-12-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDC\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-19","recordDate":"2015-05-21","paymentDate":"2015-05-22","value":0.1054201,"currency":"USD"},{"executeDate":"2015-06-16","recordDate":"2015-06-18","paymentDate":"2015-06-19","value":0.1094172,"currency":"USD"},{"executeDate":"2015-07-21","recordDate":"2015-07-23","paymentDate":"2015-07-24","value":0.0106339,"currency":"USD"},{"executeDate":"2015-08-18","recordDate":"2015-08-20","paymentDate":"2015-08-21","value":0.1070379,"currency":"USD"},{"executeDate":"2015-09-22","recordDate":"2015-09-24","paymentDate":"2015-09-25","value":0.167621,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDC\",market:\"US\",delay:false,,,undefined,":{}}}